Data gathered: July 12
AI Stock Analysis - Novo Nordisk (NVO)
Analysis generated July 3, 2025. Powered by Chat GPT.
Novo Nordisk is a global healthcare company headquartered in Denmark. The company specializes in diabetes care and is renowned for its innovative insulin products and devices. They also have a significant presence in other therapeutic areas such as hemophilia, growth disorders, and obesity care. With a strong commitment to research and development, Novo Nordisk has established itself as a leader in its domain.
Stock Alerts - Novo Nordisk (NVO)
 |
Novo Nordisk | July 10 Over the past few months, there has been an downward trend in Web Traffic. |
|
Novo Nordisk | June 26 Reddit mentions are up by 172% in the last 24h. |
|
Novo Nordisk | June 24 Reddit mentions are up by 1169% in the last 24h. |
|
Novo Nordisk | June 23 Trending on Reddit. |
Download our app to get future alerts delivered in real-time.
Alternative Data for Novo Nordisk
About Novo Nordisk
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents.
| Price | $68.93 |
| Target Price | Sign up |
| Volume | 6,510,000 |
| Market Cap | $324B |
| Year Range | $58.08 - $110.2 |
| Dividend Yield | 2.34% |
| PE Ratio | 19.24 |
| Analyst Rating | 57% buy |
| Industry | Drug Manufacturers |
In the news
 |
Novo Nordisk A/S (NVO): “Canada’s A Backdoor,” Says Jim CramerJuly 12 - Yahoo Entertainment |
Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over “Deceptive” Marketing of Wegovy– Hagens BermanJuly 11 - GlobeNewswire |
|
 |
Novo Nordisk: The Market Doesn't Get ItJuly 10 - SeekingAlpha |
 |
Novo Nordisk (NVO) Beats Stock Market Upswing: What Investors Need to KnowJuly 10 - Yahoo |
|
The Zacks Analyst Blog Highlights SAP SE, Novo Nordisk, Thermo Fisher Scientific and FONARJuly 9 - Yahoo |
Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over “Deceptive” Marketing of Wegovy – Hagens BermanJuly 9 - GlobeNewswire |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 78.1B | 12.9B | 65.2B | 29B | 46B | 6.530 |
| Q4 '24 | 85.7B | 13B | 72.7B | 28.2B | 34.9B | 6.340 |
| Q3 '24 | 71.3B | 11.3B | 60B | 27.3B | 37.4B | 6.120 |
| Q2 '24 | 68.1B | 10.3B | 57.8B | 20.1B | 35.7B | 0.660 |
| Q1 '24 | 65.3B | 9.92B | 55.4B | 25.4B | 35.3B | 0.830 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Johnson & JohnsonJNJ |
$156.9 0% | 36 |
 |
Eli Lilly and CompanyLLY |
$793.01 0% | 61 |
 |
PfizerPFE |
$25.65 0% | 54 |
 |
AstrazenecaAZN |
$71.13 0% | 58 |
 |
AbbVieABBV |
$192.45 0% | 46 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Laurel Lee |
Jun 23, 25 | Sell | $1K - $15K |
| Byron Donalds |
Apr 15, 25 | Sell | $1K - $15K |
| Scott Franklin |
Apr 11, 25 | Buy | $1K - $15K |
Read more about Novo Nordisk (NVO) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Novo Nordisk?
The Market Cap of Novo Nordisk is $324B.
What is Novo Nordisk's PE Ratio?
As of today, Novo Nordisk's PE (Price to Earnings) ratio is 19.24.
What is the current stock price of Novo Nordisk?
Currently, the price of one share of Novo Nordisk stock is $68.93.
How can I analyze the NVO stock price chart for investment decisions?
The NVO stock price chart above provides a comprehensive visual representation of Novo Nordisk's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Novo Nordisk shares. Our platform offers an up-to-date NVO stock price chart, along with technical data analysis and alternative data insights.
Does NVO offer dividends to its shareholders?
Yes, Novo Nordisk (NVO) offers dividends to its shareholders, with a dividend yield of 2.34%. This dividend yield represents Novo Nordisk's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Novo Nordisk in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Novo Nordisk?
Some of the similar stocks of Novo Nordisk are Johnson & Johnson, Eli Lilly and Company, Pfizer, Astrazeneca, and AbbVie.
.